Niagen Bioscience, Inc. Common Stock (NAGE) is a publicly traded Healthcare sector company. As of July 8, 2026, NAGE trades at $3.42 with a market cap of $278.76M and a P/E ratio of 16.02. NAGE moved -0.58% today. Year to date, NAGE is -46.76%; over the trailing twelve months it is -72.27%. Its 52-week range spans $3.18 to $14.69. Analyst consensus is strong buy with an average price target of $11.25. Rallies surfaces NAGE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NAGE, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $3.42 |
| Market Cap | $278.76M |
| P/E Ratio | 16.02 |
| EPS | $0.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.69 |
| 52-Week Low | $3.18 |
| Volume | 546.61K |
| Avg Volume | 0 |
| Revenue (TTM) | $129.42M |
| Net Income | $17.38M |
| Gross Margin | 64.28% |
4 analysts cover NAGE: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.25.